Palermo, Giuseppe
 Distribuzione geografica
Continente #
EU - Europa 9.520
NA - Nord America 1.485
AS - Asia 486
AF - Africa 23
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 2
Totale 11.540
Nazione #
IT - Italia 7.808
US - Stati Uniti d'America 1.436
DE - Germania 563
SE - Svezia 307
CN - Cina 180
NL - Olanda 176
FR - Francia 147
SG - Singapore 138
UA - Ucraina 124
GB - Regno Unito 82
IE - Irlanda 78
ID - Indonesia 50
IN - India 47
CH - Svizzera 44
CA - Canada 39
RU - Federazione Russa 35
FI - Finlandia 33
BE - Belgio 28
ES - Italia 19
JP - Giappone 17
PL - Polonia 15
TR - Turchia 15
MA - Marocco 11
BR - Brasile 8
HK - Hong Kong 8
GR - Grecia 7
IR - Iran 7
RO - Romania 7
CZ - Repubblica Ceca 6
AT - Austria 5
EU - Europa 5
PA - Panama 5
TH - Thailandia 5
CI - Costa d'Avorio 4
LT - Lituania 4
MX - Messico 4
SM - San Marino 4
TW - Taiwan 4
AR - Argentina 3
BG - Bulgaria 3
MD - Moldavia 3
PT - Portogallo 3
RS - Serbia 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
CL - Cile 2
CV - Capo Verde 2
EC - Ecuador 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
IS - Islanda 2
KR - Corea 2
MT - Malta 2
MY - Malesia 2
PH - Filippine 2
PK - Pakistan 2
SK - Slovacchia (Repubblica Slovacca) 2
UG - Uganda 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BZ - Belize 1
CO - Colombia 1
EE - Estonia 1
EG - Egitto 1
IM - Isola di Man 1
KG - Kirghizistan 1
LK - Sri Lanka 1
ME - Montenegro 1
NO - Norvegia 1
PE - Perù 1
SA - Arabia Saudita 1
VN - Vietnam 1
Totale 11.540
Città #
Milan 808
Rome 556
Chandler 347
Naples 228
Turin 166
Ashburn 137
Florence 115
Singapore 113
Palermo 109
Bologna 108
Genoa 82
Catania 78
Dublin 76
Jacksonville 74
Ann Arbor 73
Bari 73
San Mateo 69
Wilmington 54
Jakarta 46
Verona 46
Nanjing 43
Venice 42
Brescia 39
Bremen 32
Padova 32
Dearborn 31
New York 31
Los Angeles 30
Messina 28
Ottawa 28
Parma 28
Bergamo 27
Perugia 26
Cattolica 25
Livorno 25
Nürnberg 24
Redwood City 24
Salerno 24
Marseille 23
Reggio Emilia 23
Brussels 22
Lawrence 22
Pescara 22
Woodbridge 21
Moscow 20
Lucca 19
Munich 19
Trieste 19
Cagliari 18
Monza 17
Taranto 17
Boston 16
Falls Church 16
Modena 16
Nanchang 16
Princeton 16
Houston 15
Lancaster 15
Rimini 15
Caserta 13
Cesano Maderno 12
Lecce 12
Novara 12
Piacenza 12
Mountain View 11
Redmond 11
Tianjin 11
Udine 11
Kraków 10
Porto Sant'Elpidio 10
Vicenza 10
Beijing 9
Catanzaro 9
Kunming 9
Macerata 9
Nova Milanese 9
San Benedetto del Tronto 9
Zurich 9
Angri 8
Benevento 8
Boardman 8
Centro 8
Cesena 8
Chicago 8
Fairfield 8
Fano 8
Gorle 8
Helsinki 8
Hong Kong 8
La Spezia 8
Lamezia Terme 8
Leawood 8
Pavia 8
Pisa 8
Portici 8
Terni 8
Trento 8
Valenzano 8
Vercelli 8
Amsterdam 7
Totale 4.657
Nome #
Le disfunzioni sessuali maschili in pazienti con insufficienza renale cronica end stage ed in pazienti sottoposti a trapianto renale 7.999
La tecnologia robotica nel contesto urologico italiano: analisi economica costo-efficacia 300
High-intensity focused ultrasound in prostate cancer: Today's outcomes and tomorrow's perspectives 253
Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma 144
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary results 144
Urological complications following inguinal hernioplasty 134
Robot technology in the Italian Health-CARE system: cost-efficacy economic analysis 123
IMAGING IN BLADDER CANCER: PRESENT ROLE AND FUTURE PERPECTIVES.Totaro A, Pinto F, Brescia A, Racioppi M, Cappa E, D'Agostino D, Volpe A, Sacco E, Palermo G, Valentini AL, Bassi PF. 114
Hot topics in urological health economics. A mini review 111
Positive surgical margins in nephron sparing surgery for renal cell carcinoma 111
Postoperative Quality of Life in Patients with Ileal Neobladder at Short-, Intermediate- and Long-Term Follow-Up 105
Clinical, pathological and molecular prognostic factors in prostate cancer decision-making process 104
Imaging in prostate cancer staging: present role and future perspectives 98
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 96
Male sexual dysfunction in patients with chronic end-stage renal insufficiency and in renal transplant recipients 96
Surgery for male urinary incontinence: where are we now and what is in the pipeline? 95
Is microsurgical technique really necessary in inguinal or sub-inguinal surgical treatment of varicocele? 93
Thermochemotherapy for non-muscle-invasive bladder cancer: is there a chance to avoid early cystectomy? 89
Therapeutic strategies in penile cancer: state of the art 89
Value of Current Chemotherapy and Surgery in Advanced and Metastatic Bladder Cancer 88
The occult urothelial cancer 88
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 86
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study. 76
Focal surgery in testis cancer: current state of the art 73
The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients 73
Circulating tumor cells as prognostic biological marker in different stages prostate cancer and the effect of different therapeutic approaches on their expression 67
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer 62
Improved non-invasive diagnosis of bladder cancer with an electronic nose: A large pilot study 61
Artificial urinary sphincter significantly better than fixed sling for moderate post-prostatectomy stress urinary incontinence: a propensity score-matched study 60
Objectively improving appropriateness of absorbent products provision to patients with urinary incontinence: The DIAPPER study 58
Metanephric adenoma with BRAF V600K mutation and a doubtful radiological imaging: pitfalls in the diagnostic process 56
Can Neutrophil-to-Lymphocyte ratio predict the response to BCG in high-risk non muscle invasive bladder cancer? 54
Second-Line Conservative Device-Assisted Intravesical Treatment in Selected Patients With Recurrent High-Risk Non–Muscle-Invasive Bladder Cancer 51
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer 50
Implementation of frailty preoperative assessment to predict outcome in patients undergoing urological surgery: a systematic review and meta-analysis 46
[Sport, infertility and erectile dysfunction] 37
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group 34
The Role of Bladder Epicheck Test In Follow-Up of Patients with Non-Muscle Invasive Bladder Cancer 34
Bladder tumor markers: A review of the literature 30
How to reduce bacillus Calmette-Guérin discontinuation in patients with severe functional impairment 21
The indispensable role of urinalysis for patients undergoing treatment for nonmuscle invasive bladder cancer 18
Imaging in bladder cancer: Present role and future perspectives 18
Rate of clinically significant prostate cancer on repeat saturation biopsy after a diagnosis of atypical small acinar proliferation 16
Methylation Analysis of Urinary Sample in Non-Muscle-Invasive Bladder Carcinoma: Frequency and Management of Invalid Result 13
The new surgical robotic platform HUGOTM RAS: System description and docking settings for robot-assisted radical prostatectomy 13
Post nephrectomy management of localized renal cell carcinoma. From risk stratification to therapeutic evidence in an evolving clinical scenario 13
Totale 11.594
Categoria #
all - tutte 23.556
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.556


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020267 0 0 0 0 0 26 36 22 64 25 55 39
2020/2021360 10 28 14 30 56 29 45 13 36 13 58 28
2021/2022464 38 29 5 38 36 35 15 62 26 37 69 74
2022/20232.159 173 150 88 196 85 180 98 181 228 174 351 255
2023/20244.326 258 336 300 332 323 346 369 399 343 431 438 451
2024/20253.141 471 574 579 527 605 385 0 0 0 0 0 0
Totale 11.594